Skip to content

2023 # 452 Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies

CMS Measure ID: #452 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Patient Safety MeasureContinue reading “2023 # 452 Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies”

2023 # 451 RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy

CMS Measure ID: #451 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 451 RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy”